SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-022976
Filing Date
2013-04-19
Accepted
2013-04-19 21:50:51
Documents
2
Period of Report
2013-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd377293.html 3  
1 FORM 3 rrd377293.xml 3 6678
2 POWER OF ATTORNEY rrd339100_383089.htm EX-24. 5371
  Complete submission text file 0001181431-13-022976.txt   13689
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address
Aphale Jayant (Reporting) CIK: 0001574696 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 13772625